Adverse Drug Reaction Analysis Methods and Research Trends by Data Sources for Post-marketing Surveillance
Journal of Health Informatics and Statistics. 2022;47(Suppl 3):S41-S50 
FDA's Adverse Drug Reaction Drug Dictionary and its Role in Post-Marketing Surveillance
Drug Information Journal. 1986;20(2):135-145
POST-MARKETING SURVEILLANCE OF ADVERSE DRUG REACTIONS
InPharma. 1977;110(1):4-5
Alert systems for post-marketing surveillance of adverse drug events— Methods and problems
Controlled Clinical Trials. 1991;12(5):659
Decision support methods for the detection of adverse events in post-marketing data
Drug Discovery Today. 2009;14(7-8):343-357
Medical databases in post-marketing drug surveillance
Trends in Pharmacological Sciences. 1986;7:377-380
Post-marketing drug surveillance and C.I.I.F.T.: Experiences concerning organization and data process
Pharmacological Research. 1990;22:134
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual
Pharmacoepidemiology and Drug Safety. 2013;22(5):488-495
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance
Drug Safety. 2015;38(12):1211-1218
Centralized data sources and QSAR methods for the prediction of idiosyncratic adverse drug reaction
QSAR in Safety Evaluation and Risk Assessment. 2023;273-292